Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIcahn School of Medicine at Mount Sinai

About this trial

This project includes testing circadian reset technology (CRT) on frequency of binge eating in a sample of 40 individuals with binge eating disorder. Participants will be randomized to one of two groups. Both groups use a virtual reality (VR) headset for 10 minutes (5 upon waking, 5 before sleep) daily for 1 month. One group will use the CRT software on the headset and the other group will use a software intended to be a control. Measures will be taken at baseline and 1-month. The researchers anticipate that use of CRT will improve sleep quality leading to increased appetitive control.

Eligibility criteria

Qualifiers

Ages 18+

Diagnosed with Binge Eating Disorder using EDA-5

English-speaking

Disqualifiers

Pregnancy

Acute suicide risk/active suicidal ideation

PSQI score <5 indicating good sleep quality

A condition that may create a risk while using the VR headset including risk of falls, seizures, a heart condition, migraines, an eye or vision condition, or an inner ear condition.

Trial design

Treatments tested in this trial

  • Circadian Reset Technology
  • VR Headset

Treatment groups

40 Participants
are divided into 2 treatment groups